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Intratubular crystallization of calcium oxalate in the presence Exactly where and how urinary stones originate are
of membrane vesicles: An in vitro study. still unclear. Most urinary stones are located in the
Background. Since urine spends only a few minutes in the kidneys. Some are seen attached to the renal papillae.
renal tubules and has a low supersaturation with respect to
Others demonstrate signs of earlier attachment to thecalcium oxalate (CaOx), nucleation of CaOx crystals in the
kidneys, such as remains of renal tubules in small depres-kidneys is most probably heterogeneous. We have proposed
sions on stone surface [1]. Kidneys of many stone patientsthat membranes of cellular degradation products are the main
substrate for crystal nucleation. The purpose of our study was contain subepithelial plaques on their papillae [2]. These
to determine the site of membrane-mediated crystal nucleation plaques are suggested to be the sites of stone develop-
within the renal tubules and the required lag time, factors ment. Obviously, for a stone to form, crystallization mustthat determine whether crystallization results in crystalluria or
occur, and crystals must be retained in the kidneys. Sincenephrolithiasis.
urine spends only three to five minutes in the renal tu-Methods. Nucleation of CaOx was allowed to occur in five
different artificial urine solutions with ionic concentrations sim- bules and is generally undersaturated for CaOx before
ulating urine in proximal tubules (PTs), descending (DLH) reaching the collecting ducts (CDs), it is suggested that
and ascending (ALH) limbs of the loop of Henle, distal tubules nucleation of CaOx crystals within the renal tubules is
(DTs), and collecting ducts (CDs). A constant composition most probably heterogeneous [3]. Investigations of thecrystallization system was used. Experiments were run for two
ionic conditions within different segments of the nephronhours with or without the renal tubular brush border membrane
and application of the data to in vitro studies have shown(BBM) vesicles.
Results. The addition of BBM significantly reduced the nu- that urine of the loop of Henle can support calcium
cleation lag time and increased the rate of crystallization. The phosphate (CaP) nucleation [4–10]. It was proposed that
average nucleation lag time decreased from 84.6 6 43.4 minutes CaP crystals formed in the loops could promote nucle-
to 24.5 6 19 minutes in PTs, from 143.6 6 29 to 70.2 6 53.4
ation of CaOx further along the nephron in the CDs.minutes in DLH, from 17.6 6 8.6 minutes to 0.625 6 0.65 min-
The results of most in vitro crystallization studies showedutes in DTs and from 9.54 6 3.03 minutes to 0.625 6 0.65
that it took hours for the precipitation of CaP in solutionsminutes in CDs. There was no nucleation in the ALH solution
without BBM for two hours. CaOx dihydrate (COD) was com- simulating urine in the loop; however, urine spends only
mon in most solutions. Calcium phosphate (CaP) also nucle- minutes in the tubules and seconds in various segments
ated in the DLH and CD solutions. [7, 8]. Since crystallization must occur in moving urine,
Conclusions. In the absence of membrane vesicles, there
studies in one laboratory utilized a dynamic crystalliza-was no crystallization in any of the solutions within the time
tion system [7, 8]. The solution composition simulatedurine spends in the renal tubules. As a result, homogeneous
changing conditions existing in the proximal tubule (PT),nucleation of crystals anywhere within the nephron appears
unlikely. However, BBM-supported nucleation is possible in the descending limb of the loop of Henle (DLH), the
the DTs as well as CDs. A high crystallization rate in CDs ascending limb of the loop of Henle (ALH), the distal
would promote rapid crystal growth and aggregation, resulting tubule (DT), and finally to the conditions existing in the
in crystal retention within the kidneys and development of
CD. When the solution conditions became similar tonephrolithiasis.
those in the DLH, precipitation of CaP required less
than three seconds. The CaP precipitate, however, began
to dissolve in the ascending limb conditions (ALH) andKey words: nephrolithiasis, calcium phosphate, biomineralization, ma-
trix vesicles, renal stones. disappeared in the DT.
Since human kidneys slough approximately 70,000Received for publication April 13, 2000
cells per hour into the urine [11] and the matrix of kidneyand in revised form July 7, 2000
Accepted for publication July 24, 2000 stones contains cells membranes and lipids [12, 13], we
investigated the possibility that cell membranes and theirÓ 2001 by the International Society of Nephrology
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Table 1. Composition of the artificial urine solutions corresponding to the urine in each segment of the nephron
Proximal Descending limb Ascending limb Distal Collecting
tubule of the loop of the loop tubule duct
Ca21 mmol/L 1.35 7.9 1.35 0.75 7.5
Oxalate mmol/L 0.009 0.05 0.05 0.05 0.5
PO4 mmol/L 1.35 8.0 8.0 3.2 42.0
SO4 mmol/L 0.000869 0.00515 0.00515 0.00206 0.02705
Na21 mmol/L 151.5 408.7 158.7 48.9 199.0
Cl2 mmol/L 154.7 423.8 153.9 47.1 175.0
K1 mmol/L 0.0915 0.2468 0.09582 0.02953 0.12015
Mg21 mmol/L 0.99 4.0 0.59 0.3 5.0
Citrate mmol/L 0.03 0.2 0.2 0.2 2.0
pHb 6.7 7.26 6.65 6.38 6.16
pHc 6.34 6.94 6.62 6.35 6.02
Relative supersaturation 0.1771 1.596 0.7542 1.114 15.490
a Concentrations calculated
b pH of each solution prior to the addition of Ca11 or Ox
c pH measured after the addition of Ca11 and Ox to the solutions
d Added to each solution via the corresponding 50 mmol/L Ca11 and 50 mmol/L Ox solutions immediately preceding each experiment
lipids may be involved in the nucleation of CaOx [14–16]. 0.555 g of CaCl2 was added to prepare 50 mmol/L calcium
solutions from each artificial urine solution. To the re-Lipids and membranes of the vesicles produced at the
site of an injury by cellular degradation are already re- maining aliquots, 0.67 g of Na2C2O4 was added, resulting
in a 50 mmol/L oxalate. These solutions were preparedgarded as playing a critical role in CaP deposition in
numerous pathological calcification processes [17, 18]. immediately preceding each experiment. The pH of each
solution was adjusted accordingly for each location ofTo determine the involvement of membrane vesicles
of proximal tubular epithelial origin, we isolated brush- the nephron with reagent grade, 5N NaOH. The solu-
tions were filtered using Corning Costar 0.2 micron bottleborder membrane (BBM) from the kidneys of male rats.
BBMs were incubated in solutions of artificial urine that top filters (Fisher Scientific). All solutions were stored
at 88C, and new calcium and oxalate solutions were madecorresponded to the conditions of urine in the PT, DLH,
ALH, DT, and the CD. A constant composition crystalli- every two days.
zation system was used [19] so that the depleted ions
Membrane vesicleswere continuously replaced, similar to what may occur
within the kidneys. We compared lag times and nucle- Renal tubular BBM vesicles were isolated from the
kidneys of healthy Sprague-Dawley rats using Biber’sation rates and examined the types of crystals formed,
both with and without the membrane vesicles in the methodology [20]. The purity of the BBM was deter-
mined by transmission electron microscopy (TEM) andmilieu. This system allowed a comparison of the possible
effects shed membrane vesicles may have on nucleation by assaying for specific activities of marker enzymes:
alkaline phosphatase, g-glutamyl transpeptidase, andof calcium oxalate (CaOx) in different segments of the
nephron and indicated the tubular segment where crys- leucine aminopeptidase. The vesicles were stored frozen
in a Tris buffer. They were thawed and diluted with eachtallization is likely to occur.
artificial urine solution before use.
METHODS Crystallization system
Solutions Polystyrene microbeakers, cleared of particles using a
precision duster (Fisher Scientific), were used for theWe employed five artificial urine solutions equivalent
to the urinary ionic conditions at the PT, DLH, ALH, crystallization experiments. Artificial urine solutions,
corresponding to each segment of the nephron, wereDT, and the CD (Table 1). These solutions were devel-
oped by Kok and are based on micropuncture data [7]. prepared as described previously in this article. Eight
to 10 crystallization experiments were conducted withinAll solutions were made with reagent grade chemicals
purchased from Fisher Scientific (Hampton, NH, USA). each artificial urine solution. To begin each experiment,
a specific volume of artificial urine solution was pipettedThe solutions were made with deionized (DI) water and
the necessary quantities of NaCl, KCl, Na2C6H5O7 · into a microbeaker. A stir bar, stored in Chromerge
solution, was rinsed with DI water, blown dry using the2H2O, MgSO4, Na2SO4 and NaH2PO4 · H2O to obtain
the proper ionic activity for each segment. From each precision duster, and added to the microbeaker. The
microbeaker was placed into a glass-jacketed beakerof the five artificial urine solution, two 100 mL aliquots
were poured into glass bottles. To half of the aliquots, maintained at 378C with an 800 Isotherm Constant Tem-
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perature Circulator (Fisher Scientific). The glass-jack- experiment over time. The rates were calculated by aver-
aging the slopes recorded on the chart recorder, of foureted beaker was placed onto an automixer (Fisher Scien-
tific), and the stir speed was set at 2.5. The 50 mmol/L to six experiments, both with and without BBM, for each
solution. The standard error about the mean for eachcalcium and 50 mmol/L oxalate solutions, corresponding
to the artificial urine solution being examined, were point of the slope and the significance of difference be-
tween crystallization rates was calculated using Jandelloaded into separate ABU80 Autoburetts (Radiometer
America Inc., Westlake, OH, USA). The volume of cal- Scientifict Sigma Plot (version 3.0). The lag time for
nucleation, with and without BBM, was determined forcium solution needed to obtain the correct calcium ion
concentration for the solution was added to the mi- each artificial urine solution by observing the lapsed time
before calcium and oxalate were automatically added tocrobeaker through the Autoburett. The addition of cal-
cium was monitored with an Orion, model 93-20, Cal- the system. To validate the assertion that initiation of
calcium ion depletion from the solutions is indicativecium Sensing Electrode (Fisher Scientific), coupled with
a k401 Calomel Reference Electrode (Radiometer Amer- of crystal nucleation and not of simple calcium uptake
or binding by the BBM vesicles, constancy of the calciumica Inc.). Both electrodes were wired into a PHM82 Stan-
dard pH Meter (Radiometer America Inc.), which al- and oxalate concentrations and their equimolar con-
sumption was determined by periodically removing ali-lowed the calcium ion concentration to be read in mV.
The addition of calcium was recorded using a model quots, filtering and analyzing the filtrate for calcium
and oxalate and retentate for the crystals. A Student’s0555 chart recorder (Cole Parmer Instrument Co., Ver-
non Hill, IL, USA) connected to the Autoburett. The t-distribution, using Microsoftt Excel version 5.0, was
performed on the lag time data to determine the signifi-electrodes were allowed to equilibrate 10 to 20 minutes
after the addition of calcium. A stable reading of the cance of differences between the averages.
calcium concentration by the electrodes was verified
Crystal identificationwhen the rise in calcium concentration demonstrated on
the chart recorder, leveled to a straight line on the chart Samples from completed experiments were filtered
using 0.2 mm polycarbonate membrane filters (Fisherpaper. The required volume of oxalate was added to
obtain the proper relative supersaturation (RSS) for Scientific). The filters were allowed to dry and fixed with
colloidal graphite to 0.5 inch aluminum mounts (FisherCaOx for the specific solution, and the electrode allowed
to stabilize approximately one minute. A pH STAT In- Scientific). They were coated with silver using a Plasma
Sciences CrC 100 Sputtering System and were examinedterface, model 999051 (Radiometer America Inc.), was
used to reset the equipment so that the volume of oxalate with a Joel JSM 35 C (Tokyo, Japan) Scanning Electron
Microscope. The presence of crystals was verified, andadded over time during the experiment could be re-
corded with a REC 80 Servograph, model 287053, chart crystals were identified morphologically [21]. Microanal-
ysis of each sample was performed using energy disper-recorder (Radiometer America Inc.). The end point value
on a TTT80 titrator (Radiometer America Inc.) was set sive x-ray microanalysis. These data were used to deter-
mine the elementary composition of the crystals. Calciumto match the potential reading in mV on the pH meter,
and the titrator was started. The titrator was connected to phosphorous ratios were calculated from the peak
areas of calcium and phosphorous and were used toto the pH meter and both Autoburetts. Any change
in the potential (Ca21 concentration) measured by the identify the type of CaP crystals present.
electrode, triggered simultaneous and automatic addi-
tion of CaCl2 and Na2C2O4, through the Autoburetts, RESULTS
and was recorded onto the chart recorders. This allowed
Lag timethe supersaturation and ionic activity of the solution
in the reaction vessel to be monitored and maintained In the experiments using solutions simulating ionic
condition of the PT urine, the average lag time for CaOxby the calcium electrode. To half of the experiments for
each solution, 200 mL of 1 mg/mL BBM were added, crystallization exceeded 84.6 6 43.4 (mean 6 SEM) min-
utes. Following the addition of BBM, the average lagwhile the remaining experiments received 200 mL of
artificial urine with no BBM. Experiments were allowed time decreased to 24.5 6 19 minutes, a decrease of ap-
proximately 60 minutes. Statistical analysis showed theto continue for up to two hours or until between 0.5 and
1.0 mL of calcium and oxalate was added. reduction in lag time to be significant (P , 0.02). This
trend was observed for each of the remaining solutions
Analysis (Table 2).
The addition of BBM resulted in the decrease of aver-Calcium oxalate crystallization rates were determined
for all five artificial urine solutions, both with and without age CaOx nucleation lag time by approximately 73 min-
utes in DLH solutions, 17 minutes in the DT solutions,BBM. The rate of crystallization for each solution was
equated to the amount of oxalate solution added to the and 8 minutes in the CD solutions. In the absence of
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Table 2. Average lag time observed, with and without brush border membrane present, in solutions representing normal urinary conditions
in various segments of the nephron
Time minutes
With brush-border Without brush-border
Nephron segment membrane membrane P value
Proximal tubule (RSS50.180) 24.5619 (N55) 84.6643.4 (N55) ,0.02
Descending limb (RSS51.60) 70.2653.4 (N55) 143.6629 (N55) ,0.02
Ascending limb (RSS50.750) 1.2561.26 (N54) NAa (N55) ,0.001
Distal tubule (RSS51.11) 0.62560.65 (N54) 17.668.6 (N54) ,0.02
Collecting duct (RSS515.5) 0.62560.65 (N54) 9.5463.03 (N56) ,0.002
Data are mean 6 SEM. RSS is relative supersaturation.
a No nucleation after 2 hours
Fig. 1. Comparison of crystallization rates without the brush border Fig. 2. Comparison of crystallization rates with BBM in artificial urine
membrane (BBM) in artificial urine solutions representing ionic condi- solutions representing ionic conditions in various segments of a nephron.
tions in various segments of a nephron. Symbols are: (r) proximal Symbols are: (r) proximal tubule; (j) descending limb; (h) ascending
tubule; (j) descending limb; (h) ascending limb; (s) distal tubule; (3) limb; (s) distal tubule; (3) collecting duct.
collecting duct.
Table 3. Material identified in artificial urine samples
after crystallization
BBM, there was no consumption of oxalate in the solu-
With brush-border Without brush-bordertion simulating urinary ionic conditions in the ALH, Nephron segment membrane membrane
indicating lack of CaOx nucleation. However, when
Proximal tubule 11 COM 11 COMBBM was added, oxalate consumption indicating nucle- 1 COD
ation started in 1.25 6 1.26 minutes (N 5 4). Thus, a Descending limb 111 COD 11 COD
11 CaP 11 CaPsignificant difference of at least 120 minutes resulted
1 COM 1 COM(P , 0.001). Ascending limb Amorphous material NA*
Distal tubule 11 COD 11 COM
Crystallization rate 1 COD
Collecting duct 1111 COD 1111 CODIn the absence of BBM in the solutions, the crystalliza- 111 CaP 111 CaP
tion rate was extremely slow, and the addition of titrants
Abbreviations are: 1, 1 to few crystals; 1111, large number of crystals; * no
was insignificant except in the CD urine (Fig. 1). Actu- nucleation after 2 hours.
ally, there appeared to be no change after the initial
addition of calcium and oxalate. The introduction of
Crystal analysisBBM to all solutions increased the rate of crystallization
(Fig. 2). Changes were more pronounced in solutions At the end of each experiment, scanning electron mi-
simulating urine in the DLH and CD. The rate of crystal- croscopy was used to verify and identify the crystals
lization in CD urine was so rapid that the experiment (Table 3). CaOx precipitated as monoclinic plate-like
had to be stopped within 10 to 20 minutes to prevent CaOx monohydrate (COM) or tetragonal bipyramidal
overflow of titrants. Within the first minute, crystalliza- CaOx dihydrate (COD). In the PT solutions (Fig. 3),
tion in CD solution progressed at a rate of 7.0 mmol/L few crystals formed in the absence of BBM, and most
appeared to be COM. Following the addition of BBMOx/min.
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Fig. 4. (A) Crystals formed in distal limb of Henle (DLH) solution in
the presence of BBM. Both dipyramidal COD and plate-like COM
crystals (arrows) are present. Both show twinning. (B) Crystals formed
in DLH solution in the absence of BBM. Plate-like COM crystals are
only visible. Almost all crystals appear etched (arrows).
Fig. 3. (A) Crystals formed in proximal tubule (PT) solution in the
presence of brush border membrane (BBM). Calcium oxalate dihydrate
(COD) crystals with a dipyramidal habit are clearly visible. (B) Calcium
oxalate monohydrate (COM) crystals formed in PT solution in the
absence of BBM.
to the solution, a mixture of COD and COM crystals
was found. These crystals were poorly developed and
showed signs of dissolution. In the DLH solutions, crys-
tals of both CaOx and CaP were present (Figs. 4 and 5).
However, COD crystals were more common in solutions
with BBM (Fig. 4A). COM crystals formed in solution
without the BBM showed signs of dissolution with deep
etch marks and surface discontinuities (Fig. 4B). CaP
crystals were more common when no BBM was added
to the solutions. They had two distinct morphologies
(Fig. 5) and different Ca/P ratios. Crystals in the form
of rectangular (Fig. 5A) plates had a Ca/P ratio of 0.81,
while thin plate-like crystals matted into a solid mass
Fig. 5. Crystals formed in the DLH solution. (A) Columnar crystals
(Fig. 5B) had a Ca/P ratio of 1. of brushite formed in the absence of BBM. (B) Plate-like crystals of
octacalcium phosphate formed in association with the BBM.Crystallization did not occur in the ascending limb
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Fig. 6. Crystals formed in the distal tubule (DT) solution. (A) COD
Fig. 7. Crystals formed in collecting duct (CD) solutions. (A) CODcrystals formed in solution with BBM. (B) Mostly COM crystals in
crystals formed in solution with BBM. (B) A mixture of CaP and CODsolution without the BBM.
crystals formed in solution without the BBM.
solutions in the absence of BBM. Even when BBM was concerned, since supersaturation affects all aspects of
added no distinct crystals were observed. In the DT crystallization including nucleation, growth, and aggre-
solutions, COM crystals were most prominent (Fig. 6B) gation [22–25]. Nucleation in the absence of a substrate,
in the absence of BBM, with a few COD crystals. How- the homogeneous nucleation, requires higher supersatu-
ever, when BBM was added to these solutions, COD ration and a longer time. The main determinants of uri-
was the only crystal identified (Fig. 6A). Finally, in the nary supersaturation with respect to CaOx and CaP are
CD solutions, a mixture of COD and CaP was observed calcium, oxalate, phosphate, pH, citrate, and magnesium.
(Fig. 7), both with and without BBM. When BBM was The concentration of these substances changes as urine
added to the solutions, two types of CaP were found. courses through a nephron, thus affecting the supersatu-
The spherical crystals demonstrated a Ca/P of 8, while ration and potential for crystal nucleation. Estimations
wafer thin long plates had a Ca/P of 1.66. When no of CaP and CaOx supersaturations in the urine have led
BBM was present in the CD solution, wafer thin plates to the conclusion that urine is metastable with respect
demonstrated a Ca/P of 1.5, and spherical aggregates of to CaOx only in the CD [4, 7, 9]. Even in the CD urine,
small plates showed a Ca/P of 2.5.
supersaturation is not high enough for the homogeneous
nucleation of CaOx. The urinary conditions in the loops
DISCUSSION of Henle and DTs are, however, favorable for crystalliza-
tion of CaP [4–10].Investigators agree that crystallization in a solution
occurs only when it is supersaturated with the mineral The results of our studies show that nucleation of
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CaOx can occur not only in the CD, but is also possible DLH conditions. Asplin, Mandel, and Coe also reported
CaP formation in simulated DLH conditions and deter-in other segments of the nephron, and that membrane
vesicles such as BBM have a positive effect on CaOx mined that the CaP formed was of an immature moiety
such as brushite or octacalcium phosphate [5]. Thus,crystallization. The addition of BBM vesicles increased
the precipitation of COD. Our earlier studies of nephro- physiological conditions within the DLH can lead to
nucleation of CaP within the nephron. This may be evenlithiasis, in an animal model where hyperoxaluria was
induced following membrane shedding, also showed more likely in the presence of promoters such as BBM
vesicles.COD formation in association with the membrane [26].
Lieske, Toback, and Deganello demonstrated direct nu- It has been recognized that the chance for CaOx nucle-
ation decreases as urine enters the ALH because of cal-cleation of COD on surface of BSC-1 (African Green
Monkey kidney cell line) renal epithelial cells grown in cium reabsorption, which in turn lowers the RSS with
respect to CaOx. This appears to be true even in ourculture [27]. However, this does not mean that mem-
branes support COD nucleation only. We have observed studies where no crystallization was noticed with or with-
out BBM, most probably because the RSS (0.75) of ALformation of COM as well in association with the cell
membranes [28]. It is likely that other components of solution was below the metastable range for CaOx.
The CaOx RSS for the DT solution was 1.11, barelythe urine also have an influence on crystallization. For
example, the presence of magnesium in the milieu has within the metastable range for COM. However, a CaOx
RSS of 1.11, coupled with a pH of 6.38, should supportbeen deemed important in producing COD crystals in
vitro. A variety of CaP crystals formed. They had brus- heterogeneous nucleation and further crystallization. We
found that in the presence of BBM, CaOx nucleatedhite, octacalcium phosphate, and/or hydroxyapatite-like
phases of intermediate stoichiometries. within 0.625 6 0.65 minutes. However, crystallization
rates were extremely low (0.016 mmol/L Ox/min withThe PT urine was relatively dilute and stable with
respect to CaOx with an estimated CaOx RSS of 0.180. BBM and 0.010 mmol/L Ox/min without BBM). The low
crystallization rate may be attributed to the RSS of thisIt is not surprising to see a long nucleation lag time even
in the presence of BBM vesicles. Even after a few crystals solution being at the lower limit of the metastable range.
Tiselius estimated levels of supersaturation with CAPof COM formed, the solution did not begin nucleating
additional crystals or support continued growth of the and CaOx in the DT [9] and found that diurnal variations
in urine composition and pH can lead to highly supersat-crystals already present. This is reflected by the low rates
of crystallization. SEM examinations of the precipitate urated urine in the DT and promote homogeneous nucle-
ation of CaP. Homogeneous nucleation of CaOx wasformed in PT urine showed a few poorly formed crystals.
It is probable that in a solution with a RSS of 0.180, any ruled out, however. Kok reported CaOx nucleation in
DT solution in a dynamic crystallization system, butcrystals that did nucleate would quickly dissolve. Kok
determined that CaOx could form in the PT with a serum found a lack of precipitation when a static nucleation
system was used [7, 8].oxalate concentration of 50 mmol/L [7]. These conditions
are possible in the patients with primary hyperoxaluria We demonstrated the smallest nucleation lag times
and fastest overall rate for CaOx crystallization in thewhere deposits can develop not only in the kidney [29]
but in other organs as well. Similarly, rats with experi- CD solutions. This is not surprising considering the solu-
tion possessed a CaOx RSS of 15.5 and a pH of 6.16.mentally induced hyperoxaluria have been shown to de-
posit crystals in the PTs [30, 31]. The relatively rapid rate of crystallization in the CD
solution, compared with the rates observed in the otherThe CaOx RSS for the DLH solutions was 1.60, which
is within the metastable range of 1 to 6 for COM and, solutions, indicates CD solution’s readiness to support
CaOx crystallization. COD was the main CaOx crystaltherefore, on the basis of supersaturation, should support
heterogeneous nucleation of CaOx. However, the lag both in the presence and absence of BBM vesicles. Kok
found that in the dynamic nucleation system he used,time before nucleation began in these solutions was
70.2 6 53.4 minutes with BBM and was more than 120 COD formation was followed by COM formation. It is
possible that if we allowed experiments to continue forminutes when no BBM was present. These lag times are
greater than those seen for the PT solutions, even though the full 120 minutes, COM would have been observed
as well. However, because of the rapid rate in whichthe RSS with respect to CaOx for the DL is greater
than that of the PT. This is probably due to the higher crystallization occurred in this solution, the experiments
were stopped within 10 to 20 minutes to prevent over-concentrations of both the Mg21 and citrate in the DLH
solution compared with those seen in the PT solution. flow. CaP crystals were also observed, which was surpris-
ing considering the relatively low pH of the solution.Both CaOx and CaP crystals were observed. The CaOx
formed was primarily COD, with some COM. Using a However, acidic conditions can promote crystallization
of calcium hydrogen phosphate or brushite. Precipitationdynamic crystallization system, Kok determined that
CaP precipitated within three seconds in the simulated of a mixture of CaOx and CaP crystals at pH 5.5 to 6.1
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has been reported in the presence of dialyzed urine [10], crystals, both in culture [41–45] and during CaOx neph-
rolithiasis [30, 31, 34], injures the cells and induces theirwhich most likely contained membranous vesicles.
Most in vitro crystallization studies showed nucleation degradation and sloughing. Cells of the PTs are more
susceptible to oxalate-induced injury than those of thelag times of hours and days. However, urine does not
spend hours in the renal tubules [32]. According to one CDs [44]. Cellular degradation products in the form of
vesicles are clearly visible at the nucleation sites of stonesassessment, urine spends approximately 24 seconds in
PT, 40 seconds in DLH, 100 seconds in ALH (long loop [12, 13, 35] and crystal deposits [35, 46]. Membranes
isolated from rat renal tubular brush border inducenephron), 42 seconds in DT and 48 seconds in CD, for a
total of 254 seconds in the entire nephron [7]. Therefore, CaOx crystal formation in a metastable solution [28]
and are seen at the nucleation sites. Crystal deposits inbased on nucleation lag time homogeneous nucleation
of CaOx is unlikely. Even BBM-induced heterogeneous kidneys of rats with experimentally induced nephrolithi-
asis are totally surrounded by membranous vesicles andnucleation is possible in only the DT and CD where
urine spends more time than the nucleation lag time. appear connected to each other by membranes [31, 35,
46]. Shedding of membrane into the urine promotesUrine in the other segments may not support crystalliza-
tion because of the length of time it takes for nucleation CaOx crystallization in the rats [26]. We have proposed
that renal epithelial injury particularly to the PT is ato begin is longer than the urinary residence time. Kok
showed nucleation of CaP in DLH within seconds only risk factor for nephrolithiasis [47, 48]. Injured cells are
released from basement membrane both as whole unitswhen a dynamic crystallization system was used [7, 8].
However, the precipitate disappeared once the condi- or small membrane-bound fragments and vesicles [31,
34, 48]. These membranes act as heterogeneous nuclea-tions were changed to simulate those existing in the
ALH. CaOx precipitated when the ionic environment tors of CaOx crystals. They also support crystal aggrega-
tion by joining various crystals together [46]. Associationmimicked the DT conditions. Kok proposed that dissolv-
ing CaP promoted the nucleation of CaOx. Our ultra- of cellular degradation products with the crystals and
their eventual incorporation into the growing aggregatesstructural studies of kidney stones and crystal deposits
in both the human and rat kidneys have shown that increases the mass with obvious consequence of being
retained inside the nephron due to its size. For example,an organic coat always surrounds the crystals [33]. The
intranephronic crystals are always seen in association a 5 mm CaOx crystal attached to a 5 to 30 mm cell or
cell fragment can increase the crystal size to approxi-with cellular degradation products [31, 34]. The coat
appears to develop as soon as crystals are formed and mately 10 to 35 mm.
Earlier, we presented evidence for the involvement ofconsists of adsorbed proteins and lipids [35]. Biological
crystals are actually a crystal-matrix unit [12]; therefore, membrane vesicles in promotion of CaOx crystallization
in an in vivo rat model [26, 34]. Our present in vitrocrystals formed in the DLH will soon become associated
with organic material consisting of proteins, lipids, and physicochemical study demonstrated that membrane
vesicles could decrease the nucleation time and increaseother membranous material. Organic materials associ-
ated with the crystals may prevent them from dissolving the rate of crystallization. An increased rate of crystalli-
zation means that crystal growth is occurring more rap-in the ALH but support heterogeneous nucleation of
CaOx further down the nephron in the DT and CD. idly than the typical formation. In addition, as the CaOx
RSS increases, the lag time before nucleation decreasesCellular membranes have long been implicated in both
physiological and pathological calcification processes. and rate of crystallization increases. As a result, it is
likely that BBM would induce crystallization earlier andMembranes of the so-called matrix vesicles have been
suggested to promote physiological calcification [36, 37], faster in the urine of stone formers, where RSS is often
elevated. This might mean that in the presence of BBMwhile membranes of cellular degradation products pres-
ent at the sites of injury have been shown to assist in vesicles, an elevated RSS coupled with changes in the
urinary crystallization inhibitory potential occurs, andpathological calcification [17, 18, 38, 39]. In both situa-
tions, membrane lipids act as nucleation substrates, while more and larger crystals could form in earlier portions
of the nephron. Numerous crystals, nucleated soonervarious proteins and glycosaminoglycans modulate crys-
tal growth and aggregation. Our morphological studies and in earlier portions of the nephron may give added
time for crystal growth, thus increasing the likelihood ofof kidney stones [12, 33], investigations in animal model
of CaOx [31, 34] and CaP nephrolithiasis [38, 39], and in aggregation. The presence of a large number of crystals
may also increase the possibility that cellular injury oc-vitro crystallization studies [14, 15, 28, 35] have provided
evidence of similar phenomenon during the formation curs, which, in turn, increases the amount of cellular
debris in the urine and the likeliness of crystal attach-of CaOx kidney stones. The matrix of kidney stones
contains lipids, proteins, and various glycosaminoglycans ment to the injured cells [31, 34, 41, 48, 49]. Additional
cellular debris in the urine can induce further nucleation[13, 28, 40].
Exposure of renal epithelial cells to oxalate and CaOx and link crystals already present, allowing the formation
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